ARNI

DRUG2 trials

Sponsors

Novartis Pharmaceuticals, Shanghai Chest Hospital

Conditions

Advanced Lung CancerHeart Failure

Phase 2

The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension

Not yet recruitingNCT07261098

Shanghai Chest HospitalAdvanced Lung Cancer

Start: 2026-01-01End: 2028-12-31Target: 200Updated: 2025-12-03

Phase 4

Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)

TerminatedNCT04491136

Novartis PharmaceuticalsHeart Failure

Start: 2020-11-11End: 2023-06-08Updated: 2025-05-16